CLINICAL_TRIALS
trial_result
· 2011-01-07
Clinical Trial Update: Voraxaze for Delayed Methotrexate Clearance [Phase 1, Phase 2]
Summary
This clinical trial update reports results from Phase 1/2 studies of Voraxaze (glucarpidase) for managing delayed methotrexate clearance in cancer patients; the…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Hematologic Malignancy, Solid Tumor | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2011-01-07